📍 #EANMN2026 | Vienna
We will be attending European Association of Nuclear Medicine (EANM) in Vienna from October 17 to 21, in Hall 2, Booth 216. For the first time at EANM, Nancyclotep, POSIFIT, and Protherium will come together under a shared banner: Nancydium. Nancydium brings together complementary expertise, from translational research in Nancy to manufacturing for clinical trials, while supporting the expansion of therapeutic radiopharmaceutical manufacturing across Europe. We look forward to welcoming you and connecting with the nuclear medicine community, alongside our colleagues from Nancy University Hospital (CHRU de Nancy) who will also be attending the congress.